Eat broccoli to keep diabetes in check

Image
ANI Washington D.C. [U.S.A.]
Last Updated : Jun 17 2017 | 10:42 AM IST

Here's another reason to consume broccoli, as researchers have identified a new anti-diabetic substance, richly occurring in broccoli, which can significantly lower the blood sugar levels.

The findings indicated that blood sugar of the animals that received sulforaphane dropped by 23 percent in four weeks.

Study author Anders Rosengren from the University of Gothenburg said that there are strong indications that sulforaphane can become a valuable supplement to existing medication.

The objective was to find new medications against type-2 diabetes by addressing an important disease mechanism: the liver's elevated glucose production.

The classic drug metformin works by doing just that, but often causes gastric side-effects and can also not be taken when kidney function is severely reduced, which affects many with diabetes.

They analysed 2,800 participants investigated and found that sulforaphane proved to have the best characteristics for the task.

An antioxidant that was previously studied for the treatment of cancer and inflammatory disease, but not for diabetes was thereby identified.

Cell experiments were followed by animal studies on rats and mice with dietary-induced diabetes.

The blood sugar of the animals that received sulforaphane dropped by 23 percent in four weeks, and by 24 percent in those given metformin.

Anders Rosengren explained that when sulforaphane was removed from the extract, the effect disappeared and then they also looked at the genes from the liver of the animals and saw that the 50 key genes had been changed in the right direction.

A daily dose of sulforaphane is extracted from four to five kilograms of broccoli.

Anders Rosengren noted that sulforaphane targets a central mechanism in Type-2 diabetes and has a mild side-effect profile. As functional food, it can reach the patients faster than a medication, and it is also an interesting concept from a diabetes perspective, where diet is central.

The study is published in the journal Science Translational Medicine.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 17 2017 | 10:04 AM IST

Next Story